{"component": "clause", "props": {"groups": [{"snippet_links": [{"key": "in-the-event", "type": "clause", "offset": [0, 12]}, {"key": "a-third-party", "type": "clause", "offset": [13, 26]}, {"key": "patent-invalidity", "type": "clause", "offset": [71, 88]}, {"key": "licensed-patents", "type": "clause", "offset": [131, 147]}, {"key": "right-to-defend", "type": "clause", "offset": [188, 203]}, {"key": "cost-and-expense", "type": "clause", "offset": [227, 243]}, {"key": "to-control", "type": "definition", "offset": [249, 259]}, {"key": "licensed-product", "type": "clause", "offset": [348, 364]}, {"key": "during-the-term-of-this-agreement", "type": "clause", "offset": [365, 398]}, {"key": "obligation-to-pay-royalties", "type": "clause", "offset": [411, 438]}, {"key": "in-accordance", "type": "definition", "offset": [453, 466]}, {"key": "royalty-reduction", "type": "clause", "offset": [483, 500]}, {"key": "section-43", "type": "clause", "offset": [517, 528]}], "snippet": "In the event a third Party brings an action to obtain a declaration of patent invalidity against Luitpold, BMPI and/or one or more Licensed Patents, BMPI (or its Licensors) shall have the right to defend such action at its own cost and expense, and to control any ensuing litigation. In the event a competitor is successful in lawfully marketing a Licensed Product during the term of this Agreement, Luitpold's obligation to pay royalties shall persist in accordance solely with the royalty reduction as set forth in Section 4.3.", "samples": [{"hash": "maXwQlRPyc", "uri": "/contracts/maXwQlRPyc#declaratory-judgment-action", "label": "Exclusive Sublicense Agreement (Biomimetic Therapeutics, Inc.)", "score": 19.0, "published": true}, {"hash": "dmQDV5SZZgk", "uri": "/contracts/dmQDV5SZZgk#declaratory-judgment-action", "label": "Exclusive Sublicense Agreement (Biomimetic Therapeutics, Inc.)", "score": 19.0, "published": true}, {"hash": "77NaCZtbznC", "uri": "/contracts/77NaCZtbznC#declaratory-judgment-action", "label": "Exclusive Sublicense Agreement (Biomimetic Therapeutics, Inc.)", "score": 19.0, "published": true}], "size": 4, "hash": "48ac121539138cff4294556161ecc43d", "id": 3}, {"snippet_links": [{"key": "the-right", "type": "clause", "offset": [17, 26]}, {"key": "the-obligation", "type": "clause", "offset": [36, 50]}, {"key": "to-file", "type": "definition", "offset": [52, 59]}, {"key": "court-of-competent-jurisdiction", "type": "definition", "offset": [99, 130]}, {"key": "infringement-of", "type": "clause", "offset": [162, 177]}, {"key": "third-party-patent", "type": "definition", "offset": [182, 200]}, {"key": "relating-to", "type": "definition", "offset": [201, 212]}, {"key": "neose-technology", "type": "clause", "offset": [228, 244]}], "snippet": "Neose shall have the right, but not the obligation, to file any declaratory judgment action in any court of competent jurisdiction as to questions of validity or infringement of any Third Party patent relating to the use of the Neose Technology.", "samples": [{"hash": "l23Gp4EiEf7", "uri": "/contracts/l23Gp4EiEf7#declaratory-judgment-action", "label": "Research, Development and License Agreement (Neose Technologies Inc)", "score": 21.0, "published": true}, {"hash": "bBjufmra329", "uri": "/contracts/bBjufmra329#declaratory-judgment-action", "label": "Research, Development and License Agreement (Neose Technologies Inc)", "score": 21.0, "published": true}, {"hash": "93xFXmSaXJ7", "uri": "/contracts/93xFXmSaXJ7#declaratory-judgment-action", "label": "Research, Development and License Agreement (Neose Technologies Inc)", "score": 21.0, "published": true}], "size": 5, "hash": "bbb271574bb7a62fb4d566fe835015cf", "id": 1}, {"snippet_links": [{"key": "between-the-parties", "type": "clause", "offset": [27, 46]}, {"key": "concerning-the", "type": "clause", "offset": [47, 61]}, {"key": "interpretation-of-this-agreement", "type": "clause", "offset": [62, 94]}, {"key": "it-is-agreed-that", "type": "clause", "offset": [96, 113]}, {"key": "district-court", "type": "definition", "offset": [164, 178]}, {"key": "declaratory-judgment", "type": "definition", "offset": [210, 230]}, {"key": "cause-shall", "type": "definition", "offset": [268, 279]}, {"key": "district-payment", "type": "clause", "offset": [353, 369]}, {"key": "property-owner", "type": "clause", "offset": [375, 389]}, {"key": "final-determination", "type": "clause", "offset": [405, 424]}, {"key": "to-the-city", "type": "definition", "offset": [450, 461]}, {"key": "due-date", "type": "clause", "offset": [469, 477]}, {"key": "preceding-period", "type": "definition", "offset": [534, 550]}, {"key": "amount-owed", "type": "clause", "offset": [603, 614]}, {"key": "owner-agrees-to", "type": "clause", "offset": [663, 678]}, {"key": "additional-amount", "type": "definition", "offset": [690, 707]}, {"key": "potential-liability", "type": "clause", "offset": [711, 730]}, {"key": "the-registry", "type": "clause", "offset": [734, 746]}, {"key": "determination-of-the", "type": "clause", "offset": [812, 832]}, {"key": "further-appeal", "type": "clause", "offset": [856, 870]}], "snippet": "If any disagreement arises between the parties concerning the interpretation of this Agreement, it is agreed that either of the said parties may petition any Civil District Court of \u2587\u2587\u2587\u2587\u2587\u2587 County, Texas, for a Declaratory Judgment determining said controversy and the cause shall be tried as other civil causes. If the controversy affects an Industrial District Payment, the Property Owner shall, pending final determination of said controversy, pay to the City on the due date the same amount which was paid to the City for the last preceding period as to which there was no controversy concerning the amount owed by the Property Owner to the City. The Property Owner agrees to tender any additional amount of potential liability to the registry of the Civil District Court, \u2587\u2587\u2587\u2587\u2587\u2587 County, Texas, pending final determination of the controversy beyond any further appeal.", "samples": [{"hash": "bIfBU2jk1O5", "uri": "/contracts/bIfBU2jk1O5#declaratory-judgment-action", "label": "Industrial District Agreement", "score": 22.0841889117, "published": true}, {"hash": "69loIoV1HP0", "uri": "/contracts/69loIoV1HP0#declaratory-judgment-action", "label": "Industrial District Agreement", "score": 20.3976728268, "published": true}], "size": 5, "hash": "9e870f6dfa05bb3c680ae1db19cc398c", "id": 2}, {"snippet_links": [{"key": "to-waive", "type": "clause", "offset": [14, 22]}, {"key": "right-to", "type": "definition", "offset": [27, 35]}, {"key": "with-respect-to", "type": "clause", "offset": [72, 87]}, {"key": "notice-of-violation-or-default", "type": "clause", "offset": [92, 122]}, {"key": "pursuant-to", "type": "definition", "offset": [128, 139]}, {"key": "provision-of", "type": "clause", "offset": [144, 156]}], "snippet": "Tenant agrees to waive its right to bring a declaratory judgment action with respect to any notice of violation or default sent pursuant to any provision of this Lease.", "samples": [{"hash": "2dRjMx5WjpX", "uri": "/contracts/2dRjMx5WjpX#declaratory-judgment-action", "label": "Lease Agreement (HS Spinco, Inc.)", "score": 29.9828884326, "published": true}, {"hash": "75dkrmNKC2U", "uri": "/contracts/75dkrmNKC2U#declaratory-judgment-action", "label": "Office Lease (DiaMedica Therapeutics Inc.)", "score": 29.8323066393, "published": true}, {"hash": "j5k364RQENr", "uri": "/contracts/j5k364RQENr#declaratory-judgment-action", "label": "Office Lease (DiaMedica Therapeutics Inc.)", "score": 29.6516084873, "published": true}], "size": 3, "hash": "7775b9024b20a302a7285bc87ac218fd", "id": 4}, {"snippet_links": [{"key": "in-the-event", "type": "clause", "offset": [0, 12]}, {"key": "a-third-party", "type": "clause", "offset": [13, 26]}, {"key": "patent-invalidity", "type": "clause", "offset": [71, 88]}, {"key": "licensed-patents", "type": "clause", "offset": [122, 138]}, {"key": "right-to-defend", "type": "clause", "offset": [169, 184]}, {"key": "cost-and-expense", "type": "clause", "offset": [208, 224]}, {"key": "to-control", "type": "definition", "offset": [230, 240]}, {"key": "been-redacted", "type": "clause", "offset": [298, 311]}, {"key": "the-securities-and-exchange-commission", "type": "clause", "offset": [338, 376]}, {"key": "pursuant-to-a", "type": "definition", "offset": [377, 390]}, {"key": "request-for-confidential-treatment", "type": "clause", "offset": [391, 425]}, {"key": "pursuant-to-rule", "type": "clause", "offset": [426, 442]}, {"key": "securities-act-of-1933", "type": "clause", "offset": [457, 479]}, {"key": "as-amended", "type": "definition", "offset": [481, 491]}], "snippet": "In the event a third party brings an action to obtain a declaration of patent invalidity against Licensor and one or more Licensed Patents, Licensor shall have the sole right to defend such action at its own cost and expense, and to control any ensuing litigation. ** REPRESENTS MATERIAL WHICH HAS BEEN REDACTED AND SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED.", "samples": [{"hash": "hfu4snBsKyh", "uri": "/contracts/hfu4snBsKyh#declaratory-judgment-action", "label": "Exclusive Patent License Agreement (Biomimetic Therapeutics, Inc.)", "score": 19.0, "published": true}, {"hash": "hZlx4ufliio", "uri": "/contracts/hZlx4ufliio#declaratory-judgment-action", "label": "Exclusive Patent License Agreement (Biomimetic Therapeutics, Inc.)", "score": 19.0, "published": true}, {"hash": "fO7FDU8nNAn", "uri": "/contracts/fO7FDU8nNAn#declaratory-judgment-action", "label": "Exclusive Patent License Agreement (Biomimetic Therapeutics, Inc.)", "score": 19.0, "published": true}], "size": 3, "hash": "ea4cf5133abd4b657631195aedaf9d48", "id": 5}, {"snippet_links": [{"key": "in-the-event", "type": "clause", "offset": [0, 12]}, {"key": "a-third-party", "type": "clause", "offset": [13, 26]}, {"key": "patent-invalidity", "type": "clause", "offset": [71, 88]}, {"key": "licensed-patents", "type": "clause", "offset": [122, 138]}, {"key": "right-to-defend", "type": "clause", "offset": [169, 184]}, {"key": "cost-and-expense", "type": "clause", "offset": [208, 224]}, {"key": "to-control", "type": "definition", "offset": [230, 240]}], "snippet": "In the event a third party brings an action to obtain a declaration of patent invalidity against Licensor and one or more Licensed Patents, Licensor shall have the sole right to defend such action at its own cost and expense, and to control any ensuing litigation.", "samples": [{"hash": "lIGUwwi0dms", "uri": "/contracts/lIGUwwi0dms#declaratory-judgment-action", "label": "Exclusive Patent License Agreement (Biomimetic Therapeutics, Inc.)", "score": 19.0, "published": true}, {"hash": "gt8lVNRAisX", "uri": "/contracts/gt8lVNRAisX#declaratory-judgment-action", "label": "Exclusive Patent License Agreement (Biomimetic Therapeutics, Inc.)", "score": 19.0, "published": true}, {"hash": "3CcXqj7DID2", "uri": "/contracts/3CcXqj7DID2#declaratory-judgment-action", "label": "Exclusive Patent License Agreement (Biomimetic Therapeutics, Inc.)", "score": 19.0, "published": true}], "size": 3, "hash": "ecafdc4f249bcbfa07eb336135ca06a0", "id": 6}, {"snippet_links": [{"key": "in-the-event-of", "type": "definition", "offset": [0, 15]}, {"key": "invalidity-or-unenforceability", "type": "clause", "offset": [32, 62]}, {"key": "relating-to", "type": "definition", "offset": [116, 127]}, {"key": "the-collaboration", "type": "clause", "offset": [160, 177]}, {"key": "the-party", "type": "clause", "offset": [191, 200]}, {"key": "notice-of", "type": "clause", "offset": [211, 220]}, {"key": "other-party", "type": "definition", "offset": [262, 273]}, {"key": "in-writing", "type": "clause", "offset": [274, 284]}, {"key": "relevant-facts", "type": "clause", "offset": [314, 328]}, {"key": "such-party", "type": "clause", "offset": [356, 366]}, {"key": "pertaining-to", "type": "definition", "offset": [367, 380]}, {"key": "the-parties-shall", "type": "clause", "offset": [397, 414]}, {"key": "consult-and-cooperate", "type": "clause", "offset": [426, 447]}, {"key": "to-determine", "type": "definition", "offset": [454, 466]}, {"key": "course-of-action", "type": "definition", "offset": [469, 485]}, {"key": "pursuant-to-article-6", "type": "clause", "offset": [526, 547]}, {"key": "in-the-case", "type": "clause", "offset": [553, 564]}, {"key": "each-party", "type": "clause", "offset": [604, 614]}, {"key": "shared-territory", "type": "clause", "offset": [648, 664]}, {"key": "both-parties", "type": "clause", "offset": [666, 678]}], "snippet": "In the event of an assertion of invalidity or unenforceability of Patents Controlled by either CombinatoRx or Fovea relating to either Licensed Combinations or the Collaboration Combination, the Party receiving notice of such assertion shall promptly advise the other Party in writing of such assertion and of all relevant facts and circumstances known to such Party pertaining to such assertion. The Parties shall thereafter consult and cooperate fully to determine a course of action, with the Party controlling prosecution pursuant to Article 6, and in the case of Fovea Collaboration Combination IP, each Party in its own Territory and, in the Shared Territory, both Parties cooperating in controlling the defense of such assertion.", "samples": [{"hash": "ai5ojW1MS3X", "uri": "/contracts/ai5ojW1MS3X#declaratory-judgment-action", "label": "Research and License Agreement (Combinatorx, Inc)", "score": 21.0, "published": true}], "size": 3, "hash": "591706c13d483669bd2f40aa28ebde62", "id": 7}, {"snippet_links": [{"key": "in-the-event", "type": "clause", "offset": [0, 12]}, {"key": "licensed-patents", "type": "clause", "offset": [101, 117]}, {"key": "of-licensee", "type": "clause", "offset": [176, 187]}, {"key": "receipt-of-notice", "type": "definition", "offset": [190, 207]}, {"key": "consent-of", "type": "clause", "offset": [251, 261]}, {"key": "action-against", "type": "clause", "offset": [357, 371]}, {"key": "provided-that", "type": "clause", "offset": [404, 417]}, {"key": "licensee-may-not", "type": "clause", "offset": [418, 434]}, {"key": "consent-judgment", "type": "clause", "offset": [448, 464]}, {"key": "materially-affects", "type": "definition", "offset": [594, 612]}, {"key": "rights-of", "type": "definition", "offset": [617, 626]}, {"key": "approval-of", "type": "clause", "offset": [668, 679]}], "snippet": "In the event that a declaratory judgment action alleging invalidity or noninfringement of any of the Licensed Patents shall be brought against UTRF, LICENSEE may, within [***] of LICENSEE\u2019s receipt of notice regarding such action and with the written consent of UTRF which shall not be unreasonably withheld, intervene and take over the sole defense of the action against UTRF at LICENSEE\u2019s own expense, provided that LICENSEE may not enter into a consent judgment acknowledging the invalidity or noninfringement of any of the Licensed Patents or an admission of fault or of wrongdoing or that materially affects the rights of UTRF hereunder without the prior written approval of UTRF, which approval shall not be unreasonably withheld.", "samples": [{"hash": "6k0ItbShkzA", "uri": "/contracts/6k0ItbShkzA#declaratory-judgment-action", "label": "License Agreement (GTX Inc /De/)", "score": 30.325119781, "published": true}, {"hash": "fGYXt8ERRw3", "uri": "/contracts/fGYXt8ERRw3#declaratory-judgment-action", "label": "License Agreement (GTX Inc /De/)", "score": 30.2073921971, "published": true}], "size": 2, "hash": "e62d3af5eadd70955221257a48e7e87e", "id": 8}, {"snippet_links": [{"key": "licensed-patents", "type": "clause", "offset": [103, 119]}, {"key": "northwestern-university", "type": "clause", "offset": [158, 181]}, {"key": "the-right", "type": "clause", "offset": [209, 218]}, {"key": "within-thirty", "type": "clause", "offset": [220, 233]}, {"key": "days-after", "type": "definition", "offset": [239, 249]}, {"key": "notice-of-the", "type": "clause", "offset": [262, 275]}, {"key": "commencement-of", "type": "clause", "offset": [276, 291]}, {"key": "the-action", "type": "clause", "offset": [352, 362]}, {"key": "no-settlement", "type": "clause", "offset": [383, 396]}, {"key": "consent-judgment", "type": "clause", "offset": [398, 414]}, {"key": "disposition-of", "type": "clause", "offset": [440, 454]}, {"key": "entered-into", "type": "clause", "offset": [474, 486]}, {"key": "consent-of", "type": "clause", "offset": [499, 509]}, {"key": "order-for-costs", "type": "definition", "offset": [648, 663]}, {"key": "related-proceedings", "type": "definition", "offset": [723, 742]}], "snippet": "If a declaratory judgment action alleging invalidity or noninfringement of any patent issuing from the Licensed Patents shall be brought against TECHNICLONE, NORTHWESTERN UNIVERSITY, at its option, shall have the right, within thirty (30) days after it receives notice of the commencement of such action, to intervene and take over the sole defense of the action at its own expense. No settlement, consent judgment or other voluntary final disposition of such action may be entered into without the consent of TECHNICLONE, which consent shall not unreasonably be withheld or delayed. NORTHWESTERN UNIVERSITY shall indemnify TECHNICLONE against any order for costs that may be made against TECHNICLONE in such action or the related proceedings.", "samples": [{"hash": "7sUziwGRrrl", "uri": "/contracts/7sUziwGRrrl#declaratory-judgment-action", "label": "License Agreement (Techniclone Corp/De/)", "score": 18.0, "published": true}], "size": 1, "hash": "57b558cd9b741f9cf109239b7143ccb5", "id": 9}, {"snippet_links": [{"key": "in-the-event-of", "type": "definition", "offset": [0, 15]}, {"key": "invalidity-or-unenforceability", "type": "clause", "offset": [32, 62]}, {"key": "joint-patent-rights", "type": "definition", "offset": [113, 132]}, {"key": "the-party", "type": "clause", "offset": [134, 143]}, {"key": "notice-of", "type": "clause", "offset": [154, 163]}, {"key": "other-party", "type": "definition", "offset": [205, 216]}, {"key": "in-writing", "type": "clause", "offset": [217, 227]}, {"key": "relevant-facts", "type": "clause", "offset": [256, 270]}, {"key": "such-party", "type": "clause", "offset": [298, 308]}, {"key": "pertaining-to", "type": "definition", "offset": [309, 322]}, {"key": "consult-and-cooperate", "type": "clause", "offset": [386, 407]}, {"key": "to-determine", "type": "definition", "offset": [414, 426]}, {"key": "course-of-action", "type": "definition", "offset": [429, 445]}, {"key": "article-13", "type": "clause", "offset": [498, 508]}, {"key": "licensed-compound", "type": "definition", "offset": [644, 661]}, {"key": "covered-by", "type": "definition", "offset": [662, 672]}, {"key": "the-family", "type": "clause", "offset": [673, 683]}, {"key": "the-claims", "type": "clause", "offset": [706, 716]}, {"key": "invalid-or-unenforceable", "type": "clause", "offset": [732, 756]}, {"key": "right-to-defend", "type": "clause", "offset": [762, 777]}], "snippet": "In the event of an assertion of invalidity or unenforceability of the CombinatoRx Patents, Angiotech Patents, or Joint Patent Rights, the Party receiving notice of such assertion shall promptly advise the other Party in writing of such assetion and of all relevant facts and circumstances known to such Party pertaining to the such assertion. Angiotech and CombinatoRx shall thereafter consult and cooperate fully to determine a course of action, with the Party controlling prosecution pursuant to Article 13 controlling the defense of such assertion; provided, however, in the event that the Party so designated is not actively Exploiting any Licensed Compound covered by the family of Patents containing the claims asserted to be invalid or unenforceable, the right to defend such assertion shall shift to the other Party if it is actively Exploiting such a Licensed Compound.", "samples": [{"hash": "1wt15F1Y8tu", "uri": "/contracts/1wt15F1Y8tu#declaratory-judgment-action", "label": "Research and License Agreement (Combinatorx, Inc)", "score": 18.0, "published": true}], "size": 1, "hash": "4c3abf46aa3802507a47d5141d0eab42", "id": 10}], "next_curs": "CmQSXmoVc35sYXdpbnNpZGVyY29udHJhY3RzckALEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2IiRkZWNsYXJhdG9yeS1qdWRnbWVudC1hY3Rpb24jMDAwMDAwMGEMogECZW4YACAA", "clause": {"title": "Declaratory Judgment Action", "size": 38, "children": [["costs", "Costs"], ["cooperation", "Cooperation"]], "parents": [["interference-opposition-and-enforcement", "Interference Opposition and Enforcement"], ["infringement", "Infringement"], ["blocking-patents", "Blocking Patents"], ["enforcement-and-defense-of-patents", "Enforcement and Defense of Patents"], ["general", "General"]], "id": "declaratory-judgment-action", "related": [["money-judgment", "Money Judgment", "Money Judgment"], ["amended-judgment", "AMENDED JUDGMENT", "AMENDED JUDGMENT"], ["infringement-proceedings", "Infringement Proceedings", "Infringement Proceedings"], ["infringement-actions", "Infringement Actions", "Infringement Actions"], ["appellate-court-orders-to-vacate-reverse-or-materially-modify-judgment", "Appellate Court Orders to Vacate, Reverse, or Materially Modify Judgment", "Appellate Court Orders to Vacate, Reverse, or Materially Modify Judgment"]], "related_snippets": [], "updated": "2025-07-07T12:37:53+00:00"}, "json": true, "cursor": ""}}